Autres langues Landfar Bio-medicine Co., Ltd

Actions

000504

CNE000000263

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
6,93 ^CNY	+1,32 %		+0,43 %	-40,26 %

11/04	Chongqing International Trust Co. a acquis 10,8 % des parts de Landfar Bio-medicine Co. auprès de Shanghai Heping Dazong Equity Investment Fund Management Co. pour un montant de 0,03 million de yuans.	CI
2023	Landfar Bio-medicine Co. Ltd publie ses résultats pour les neuf mois clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	11/04
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Landfar Bio Medicine’s Controlling Shareholder Boosts Stake to 30%	27/04/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Landfar Bio-medicine Co., Ltd completed the acquisition of additional 29% stake in Hunan Nanhua Amspring Biotechnology Co., Ltd. from Wang Yang, Luo Yi and Changsha Aishi Pulin Information Consulting Co., Ltd. for CNY 9.7 million.	10/12/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/07/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
NanHua Bio-medicine Co., Ltd announced that it expects to receive CNY 275.999987 million in funding from Hunan Chasing Fund Management Co., Ltd.	22/03/22
NanHua Bio-medicine Co., Ltd signed a letter of intent to acquire Medicine-related assets from YanAn Bicon Pharmaceutical Listed Company.	10/12/21
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	28/10/20
NanHua Bio-medicine Co., Ltd's Equity Buyback announced on October 29, 2019, has expired.	28/10/20
Hunan Finance Industry Fund Management Co., Ltd. cancelled the acquisition of 25.58% stake in NanHua Bio-medicine Co., Ltd. from Hunan Trust Co., Ltd.	10/10/20
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	27/08/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Landfar Bio-medicine Co., Ltd

Actions

000504

CNE000000263

Autres langues

Filtres